(A Top Pick Mar 20/18, Down 1%) He still thinks it is amazing. There is still massive growth in front of them.

(A Top Pick Mar 20/18, Down 0.2%) It was one of his hopes in the medical area for great growth. They are being acquired. He is going to keep holding it.

(A Top Pick Mar 20/18, Down 33%) He has owned it since it went public. It has had a lot of ups and downs but is an incredibly well managed company. They have lift access as well as farm machinery businesses in addition to auto parts. He would not hesitate to buy it.

It is well managed. They made a plethora of acquisitions. They are making tiny ones with a model that works. Don’t sell a company doing this well, although he prefers OTEX-T, which is a more sure bet. (Analysts’ price target is $11.32)

They are a core holding in the medical area. They have done well recently. They will not make a home run because they make commodities. They are big and they dominate the business. As hospital spending picks up they will get their share. You will get more upside from other companies if their drugs come through. He would not hesitate to own ABT-N. It is slow and steady.

They suffered badly. It is going to disappear as they are being acquired. You could hold it from here.

They have hope for a bunch of new products. There is heavy competition with slow growth. He prefers OTEX-T, FB-Q, or GOOGL-Q.